Kun Zou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kun Zou has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Wei-Qiao Deng
Hubei Key Laboratory of Natural Products Research and Development, College of Chemistry & Life Science, China Three Gorges University, Yichang, Hubei, China; Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, Liaoning, China
2 shared publicationsHua-Jun Luo
Hubei Key Laboratory of Natural Products Research and Development, College of Chemistry & Life Science, China Three Gorges University, Yichang, Hubei, China
1 shared publication- Hua-Jun Luo
China Three Gorges University
1 shared publication Jun-Zhi Wang
College of Chemistry & Life Science, China Three Gorges University
1 shared publication
Latest Publications
- Open Access
- 20 May 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (5) , e97688
Protonated Form: The Potent Form of Potassium-Competitive Acid Blockers
Potassium-competitive acid blockers (P-CABs) are highly safe and active drugs targeting H+,K+-ATPase to cure acid-related gastric diseases. In this study, we for the first time investigate the interaction mechanism between the protonated form of P-CABs and human H+,K+-ATPase using homology modeling, molecular docking, molecular dynamics and binding free energy calculation methods. The results explain why P-CABs have higher activities with higher pKa values or at lower pH. With positive charge, the protonated forms of P-CABs have more competitive advantage to block potassium ion into luminal channel and to bind with H+,K+-ATPase via electrostatic interactions. The binding affinity of the protonated form is more favorable than that of the neutral P-CABs. In particular, Asp139 should be a very important binding site for the protonated form of P-CABs through hydrogen bonds and electrostatic interactions. These findings could promote the rational design of novel P-CABs.
- 20 May 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (5) , e97688
Open AccessProtonated Form: The Potent Form of Potassium-Competitive Acid Blockers
Potassium-competitive acid blockers (P-CABs) are highly safe and active drugs targeting H+,K+-ATPase to cure acid-related gastric diseases. In this study, we for the first time investigate the interaction mechanism between the protonated form of P-CABs and human H+,K+-ATPase using homology modeling, molecular docking, molecular dynamics and binding free energy calculation methods. The results explain why P-CABs have higher activities with higher pKa values or at lower pH. With positive charge, the protonated forms of P-CABs have more competitive advantage to block potassium ion into luminal channel and to bind with H+,K+-ATPase via electrostatic interactions. The binding affinity of the protonated form is more favorable than that of the neutral P-CABs. In particular, Asp139 should be a very important binding site for the protonated form of P-CABs through hydrogen bonds and electrostatic interactions. These findings could promote the rational design of novel P-CABs.
- 3 February 2013
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 22 (10) , 4970-4979
Induced-fit docking and binding free energy calculation on furostanol saponins from Tupistra chinensis as epidermal growth factor receptor inhibitors
- 3 February 2013
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 22 (10) , 4970-4979
Induced-fit docking and binding free energy calculation on furostanol saponins from Tupistra chinensis as epidermal growth factor receptor inhibitors